Skip to main content
Skip to content
1 duplicate copy in the archive
Case File
d-21479House OversightOther

Figure 18: Historical Epidemics and Cultural Mentions

The document is a descriptive figure about disease mentions over time with no specific allegations, names, transactions, or actionable leads involving powerful actors. Tracks usage frequency of disease terms in cultural discourse. Highlights peaks for cholera, polio, AIDS/HIV, and other illnesses. Mentions Franklin D. Roosevelt's paralysis and the 1952 polio vaccine.

Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #017057
Pages
1
Persons
0
Integrity
No Hash Available

Summary

The document is a descriptive figure about disease mentions over time with no specific allegations, names, transactions, or actionable leads involving powerful actors. Tracks usage frequency of disease terms in cultural discourse. Highlights peaks for cholera, polio, AIDS/HIV, and other illnesses. Mentions Franklin D. Roosevelt's paralysis and the 1952 polio vaccine.

Tags

cultural-analysishistorical-datahouse-oversightpublic-health

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
Figure $18 1e-5 & 8 - —— - B 4.0 — fever —— diabetes — cancer =~ obesity 6 — asthma — _ heart attack iS —— tuberculosis = rs) o cS c ro) oO =| =] log low ® ® & <4 we Te 0 0. 1800 1850 1900 1950 2000 1950 1960 1970 1980 1990 2000 Year Year — cholera infantile paralysis Franklin Delano Roosevelt 1.55 polio vaccine 1 > > is) is) c c ® () 3 1.0 = lou low £ 2 re Ww 0.5 0.0 = : ~ 0.0 1800 1850 1900 1950 2000 1800 1850 1900 1950 2000 Year Year Fig. $18. Tracking historical epidemics using their influence on the surrounding culture. (A) Usage frequency of various diseases: ‘fever’ (blue), ‘cancer’ (green), ‘asthma’ (red), ‘tuberculosis’ (cyan), ‘diabetes’ (purple), ‘obesity’ (yellow) and ‘heart attack’ (black). (B) Cultural prevalence of AIDS and HIV. We highlight the year 1983 when the viral agent was discovered. (C) Usage of the term ‘cholera’ peaks during the cholera epidemics that affected Europe and the US (blue shading). (D) Usage of the term ‘infantile paralysis’ (blue) exhibits one peak during the 1916 polio epidemic (blue shading), and a second around the time of a series of polio epidemics that took place during the early 1950s. But the second peak is anomalously broad. Discussion of polio during that time may have been fueled by the election of ‘Franklin Delano Roosevelt’ (green), who had been paralyzed by polio in 1936 (green shading), as well as by the development of the ‘polio vaccine’ (red) in 1952. The vaccine ultimately eradicated ‘infantile paralysis’ in the United States.

Technical Artifacts (1)

View in Artifacts Browser

Email addresses, URLs, phone numbers, and other technical indicators extracted from this document.

Phone1800 1850

Related Documents (6)

House OversightOtherNov 11, 2025

Bill Siegel email chain discussing 'The Control Factor' and anti‑Islamic conspiracy narrative

The passage is an internal email and interview transcript promoting a conspiratorial worldview about 'Islamic Enemy' and 'Civilization Jihad.' It mentions Jeffrey Epstein as a sender but provides no c Email originates from Jeffrey Epstein's address, but only contains a casual invitation and a link to Bill Siegel outlines a theory called the 'Control Factor' that frames Islam as a coordinated threa

20p
House OversightOtherNov 11, 2025

Email chain between Lesley Groff, Jeffrey Epstein and Lisa New discussing Poetry in America campaign

The passage contains a routine correspondence about a poetry program and scheduling, with no concrete allegations, financial details, or links to high‑level officials. It mentions Jeffrey Epstein but Jeffrey Epstein is communicating with Lesley Groff and Lisa New about a poetry initiative. Lisa New references a "Templeton campaign" and seeks advice from Epstein. No specific dates, amounts, or ent

1p
House OversightUnknown

Industry overview of Curaleaf, CV Sciences, Elixinol, and Green Thumb Industries CBD product lines (Feb 2019)

Industry overview of Curaleaf, CV Sciences, Elixinol, and Green Thumb Industries CBD product lines (Feb 2019) The passage provides a market‑focused summary of several publicly traded cannabis/MSO companies and their product expansions. It contains no specific allegations, financial flows, or connections to high‑level officials, but it does mention revenue figures and growth rates that could be useful for baseline industry analysis. Because it lacks any reference to powerful actors, controversial actions, or actionable leads, its investigative value is limited. Key insights: Curaleaf launched a CBD line sold in 47 states, targeting pharmacy chains and grocery stores.; Curaleaf reported ~$45 M revenue for FY9M18 with 247% YoY growth and 57% gross margin.; CV Sciences’ PlusCBD Oi! brand generated ~$34 M revenue FY9M18, 153% YoY growth, 72% gross margin.

1p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01447597

Forwarded by Nav Gupta/db/dbcom on 10/07/2014 17:08 From: vinit To: [email protected], Cc: Paul Morris/c Nav Gupta Date: 09/07/2014 14:41 Subject: Re: Jeffrey - can we have a quick chat this am ? [C] classification: confidential Hi Jeffrey - looping in Nay and Paul. To recap: we will find a few funds, which we think have best performance characteristic and best fees for u. Loan Funds better than single loans as u don't need to bother booking single loans and servicing them. If

1p
House OversightUnknown

Discovery Dispute Over Alan Dershowitz's Document Control in Defamation Suit

Discovery Dispute Over Alan Dershowitz's Document Control in Defamation Suit The passage outlines a procedural battle over production of documents and metadata in a defamation case involving Alan Dershowitz. While it flags potential evidence that could expose communications or internal materials, it lacks concrete details about the content, dates, or parties beyond the litigants, limiting immediate investigative value. However, the mention of “control” and alleged refusal to produce metadata could merit follow‑up to determine what information is being withheld and whether it relates to broader controversies surrounding Dershowitz. Key insights: Plaintiffs allege Dershowitz is withholding documents and metadata under the claim of ‘control’.; The objection is framed as ‘word play’ and gamesmanship, suggesting possible intentional concealment.; Discovery objections focus on timeframe limits, implying plaintiffs seek records spanning an undefined period.

1p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01394143

GLDUS1 29 OF Enterpnses equity securities, or anyone else who otherwise qualifies as a Covered Person becomes subject to a disqualifying event. The Access Fund will be required to make representations to the Glendower GP that the Access Fund and anyone that is treated as a beneficial owner under Rule 506, has not been subject to a disqualifying event. To the extent that any of the foregoing persons is not able to make such representation, or becomes subject to a disqualifying event, the Gl

1p

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.